Lumixyl – Improve, Prevent or Fade Unwanted Skin Discoloration
Lumixyl is the first clinically proven medical-grade skincare system that is being used to improve, prevent or fade unwanted skin discoloration without Hydroquinone. Developed by dermatological researchers at Stanford University, Lumixyl’s ground-breaking Decapeptide-12 is the only peptide shown to measurably aid the skin in restraining tyrosinase, the enzyme responsible for initiating the overproduction of melanin, that can cause uneven pigmentation and dark spots.
Lumixyl is considered by many to be the first real alternative to Hydroquinone.
Studies show that Decapeptide-12 helps inhibit the production of melanin more efficaciously than hydroquinone – reducing melanin synthesis by as much as 40 percent compared to treatments with hydroquinone, which reduced production by only 7 percent in the same study.
Lumixyl is an effective treatment for:
- Sun Spots
- Liver Spots
- Age Spots